Advanced Biomed Inc. (ADVB)

Advanced Biomed Inc. develops microfluidic testing equipment for early cancer screening. Its platform combines semiconductor fabrication techniques with biotechnology to isolate and analyze circulating tumor cells and tumor markers found in blood samples.

The company's products integrate microfluidic modules with automation hardware and software, enabling the capture, sorting and analysis of individual tumor cells. It says the tools can support cancer screening, diagnosis, staging and treatment monitoring.

Advanced Biomed is a Nevada holding company that operates mainly through its Taiwanese subsidiary, which handles product design and development, along with a Hong Kong subsidiary. The business was established in 2014 and is headquartered in Tainan, Taiwan, and its shares trade on Nasdaq.